218 related articles for article (PubMed ID: 6314742)
1. Effects of cholecystokinin-related peptides on retention of passive avoidance behaviour.
Fekete M; Penke B; Telegdy G
Acta Physiol Acad Sci Hung; 1982; 60(4):237-42. PubMed ID: 6314742
[TBL] [Abstract][Full Text] [Related]
2. Modulation of passive avoidance behaviour of rats by intracerebroventricular administration of cholecystokinin octapeptide sulfate ester and nonsulfated cholecystokinin octapeptide.
Kádár T; Fekete M; Telegdy G
Acta Physiol Acad Sci Hung; 1981; 58(4):269-74. PubMed ID: 6291322
[TBL] [Abstract][Full Text] [Related]
3. Effects of intraventricular administration of cholecystokinin octapeptide sulfate ester and unsulfated cholecystokinin octapeptide on active avoidance and conditioned feeding behaviour of rats.
Fekete M; Szabó A; Balázs M; Penke B; Telegdy G
Acta Physiol Acad Sci Hung; 1981; 58(1):39-45. PubMed ID: 6282048
[TBL] [Abstract][Full Text] [Related]
4. Effects of cholecystokinin octapeptide sulphate ester and unsulphated cholecystokinin octapeptide on active avoidance behaviour in rats.
Fekete M; Bokor M; Penke B; Telegdy G
Acta Physiol Acad Sci Hung; 1982; 60(1-2):57-63. PubMed ID: 6306996
[TBL] [Abstract][Full Text] [Related]
5. Passive avoidance deficit following intracerebroventricular administration of cholecystokinin tetrapeptide amide in rats.
Katsuura G; Itoh S
Peptides; 1986; 7(5):809-14. PubMed ID: 3797342
[TBL] [Abstract][Full Text] [Related]
6. Effects of cholecystokinin (CCK-33) and its fragments, C-terminal octapeptide (CCK-8) and C-terminal tetrapeptide (CCK-4), on the circulatory system of diabetic rats.
Fiedorowicz RJ; Wiśniewski K
Pol J Pharmacol Pharm; 1989; 41(6):561-72. PubMed ID: 2485904
[TBL] [Abstract][Full Text] [Related]
7. Effects of sulfated cholecystokinin octapeptide and cholecystokinin tetrapeptide in rat behavior after blockade of nitric oxide synthase by L-NAME.
Hoły Z; Wiśniewski K
Rocz Akad Med Bialymst; 1998; 43():250-70. PubMed ID: 9972062
[TBL] [Abstract][Full Text] [Related]
8. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
Wiśniewska RJ
Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
[TBL] [Abstract][Full Text] [Related]
9. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of diabetic rats. Part B.
Wiśniewska RJ
Pol J Pharmacol; 1998; 50(3):213-23. PubMed ID: 9861629
[TBL] [Abstract][Full Text] [Related]
10. Further analysis of the effects of cholecystokinin octapeptides on avoidance behaviour in rats.
Fekete M; Lengyel A; Hegedüs B; Penke B; Zarándy M; Tóth G; Telegdy G
Eur J Pharmacol; 1984 Feb; 98(1):79-91. PubMed ID: 6325212
[TBL] [Abstract][Full Text] [Related]
11. The interaction of cholecystokinin and its fragments with norepinephrine in the circulatory system of diabetic rats.
Fiedorowicz RJ; Wiśniewski K
Pol J Pharmacol Pharm; 1989; 41(6):573-83. PubMed ID: 2577226
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors.
Povoski SP; Zhou W; Longnecker DS; Roebuck BD; Bell RH
Cancer Res; 1993 Sep; 53(17):3925-9. PubMed ID: 8358719
[TBL] [Abstract][Full Text] [Related]
13. Behavioral effects of cholecystokinin and its related peptides in rats.
Itoh S; Katsuura G
Prog Clin Biol Res; 1985; 192():139-45. PubMed ID: 2934743
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity studies concerning effect of cholecystokinin octapeptide on passive avoidance behaviour of rats.
Fekete M; Penke B; Telegdy G
Acta Physiol Acad Sci Hung; 1981; 58(3):197-200. PubMed ID: 6291320
[No Abstract] [Full Text] [Related]
15. The influence of C-terminal cholecystokinin fragments in the circulatory system of rats.
Wiśniewska RJ; Kupryszewski G
Pol J Pharmacol Pharm; 1992; 44(3):281-7. PubMed ID: 1470565
[TBL] [Abstract][Full Text] [Related]
16. CCK4 contains the full hormonal information of cholecystokinin in isolated pancreatic acini.
Sankaran H; Bailey AC; Willaims JA
Biochem Biophys Res Commun; 1981 Dec; 103(4):1356-62. PubMed ID: 6174128
[No Abstract] [Full Text] [Related]
17. Dopaminergic projection to the central amygdala mediates the facilitatory effect of CCK-8US and caerulein on memory in rats.
Winnicka MM; Wiśniewski K
Pharmacol Res; 1999 Jun; 39(6):445-50. PubMed ID: 10373247
[TBL] [Abstract][Full Text] [Related]
18. Structure activity relationship studies with C-terminal fragments of vasopressin and oxytocin on avoidance behaviors of rats.
de Wied D; Gaffori O; Burbach JP; Kovács GL; van Ree JM
J Pharmacol Exp Ther; 1987 Apr; 241(1):268-74. PubMed ID: 3572787
[TBL] [Abstract][Full Text] [Related]
19. Modulation of memory, reinforcement and anxiety parameters by intra-amygdala injection of cholecystokinin-fragments Boc-CCK-4 and CCK-8s.
Huston JP; Schildein S; Gerhardt P; Privou C; Fink H; Hasenöhrl RU
Peptides; 1998; 19(1):27-37. PubMed ID: 9437734
[TBL] [Abstract][Full Text] [Related]
20. Involvement of dorsolateral periaqueductal gray cholecystokinin-2 receptors in the regulation of a panic-related behavior in rats.
Bertoglio LJ; Zangrossi H
Brain Res; 2005 Oct; 1059(1):46-51. PubMed ID: 16168394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
